8-2-337, ROAD NO.3 BANJARA HILLS, HYDERABAD, K7
Provides Update on USFDA Inspection Outcome
USFDA Completes GMP Inspection at Manufacturing Facility
Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Change in Senior Managerial Personnel
Terminates Agreement with Novartis India Limited
Material disclosure
Files Form 6-K with the SEC
Annual and Transition Report of Foreign Private Issuers
Effectiveness Notice
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(3)
No filings found
Initial Statement of Beneficial Ownership
Registration Statement for Depositary Shares
Confidential Treatment Order
Submission Upload
Correspondence